Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management
Barbara Altieri, Carla Di Dato, Chiara Martini, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1332-1332
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Update on gastroenteropancreatic neuroendocrine tumors
Valentina Andreasi, Stefano Partelli, Francesca Muffatti, et al.
Digestive and Liver Disease (2020) Vol. 53, Iss. 2, pp. 171-182
Closed Access | Times Cited: 98
Recent Advances in the Treatment of Bone Metastases and Primary Bone Tumors: An Up-to-Date Review
Adrian Bădilă, Dragoş Mihai Rădulescu, Adelina-Gabriela Niculescu, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4229-4229
Open Access | Times Cited: 66
Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms
Roberta Modica, Alessia Liccardi, Roberto Minotta, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 19, Iss. 1, pp. 49-61
Open Access | Times Cited: 9
Pancreatic Neuroendocrine Neoplasms: Does Sex Matter?
Giovanna Muscogiuri, Luigi Barrea, Tiziana Feola, et al.
Trends in Endocrinology and Metabolism (2020) Vol. 31, Iss. 9, pp. 631-641
Closed Access | Times Cited: 27
Bone Metabolism and Vitamin D Implication in Gastroenteropancreatic Neuroendocrine Tumors
Barbara Altieri, Carla Di Dato, Roberta Modica, et al.
Nutrients (2020) Vol. 12, Iss. 4, pp. 1021-1021
Open Access | Times Cited: 23
Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studies
Ylenia Capodanno, Barbara Altieri, Richard Elders, et al.
Translational Oncology (2021) Vol. 15, Iss. 1, pp. 101269-101269
Open Access | Times Cited: 19
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers
Luigi Asmundo, Francesco Rizzetto, Michael A. Blake, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3281-3281
Open Access | Times Cited: 2
Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection
Barbara Altieri, Anna La Salvia, Roberta Modica, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 2, pp. 330-330
Open Access | Times Cited: 6
Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice
Mauro Cives, Eleonora Pellè, Maria Rinzivillo, et al.
Neuroendocrinology (2020) Vol. 111, Iss. 3, pp. 207-216
Open Access | Times Cited: 17
68Ga‐DOTATOC‐PET/MRI and 11C‐5‐HTP‐PET/MRI are superior to 68Ga‐DOTATOC‐PET/CT for neuroendocrine tumour imaging
Hiba Jawlakh, Irina Velikyan, Staffan Welin, et al.
Journal of Neuroendocrinology (2021) Vol. 33, Iss. 6
Open Access | Times Cited: 14
Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group
Nicola Fazio, Massimo Falconi, Emanuela Foglia, et al.
Advances in Therapy (2023) Vol. 41, Iss. 1, pp. 113-129
Open Access | Times Cited: 5
Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis
Roberta Modica, Elio Benevento, Barbara Altieri, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8957-8957
Open Access | Times Cited: 1
A review of pediatric neuroendocrine tumors, their detection, and treatment by radioisotopes
Tara Haddad, Armaghan Fard‐Esfahani, Reza Vali
Nuclear Medicine Communications (2020) Vol. 42, Iss. 1, pp. 21-31
Closed Access | Times Cited: 10
Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysis
Esmeralda García‐Torralba, Francesca Spada, Kok Haw Jonathan Lim, et al.
Cancer Treatment Reviews (2021) Vol. 94, pp. 102168-102168
Closed Access | Times Cited: 9
Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors
Barbara Altieri, Luigi Barrea, Roberta Modica, et al.
Endocrine (2021) Vol. 75, Iss. 2, pp. 623-634
Closed Access | Times Cited: 9
Safety and Efficacy of 177Lu-DOTATATE in Neuroendocrine Tumor Patients With Extensive Bone Disease
Shahad Alsadik, Gopinath Gnanasegaran, Luohai Chen, et al.
Clinical Nuclear Medicine (2023) Vol. 48, Iss. 8, pp. 667-672
Open Access | Times Cited: 3
The Potential Prognostic Value of Dual-Imaging PET Parameters Based on 18F-FDG and 18F-OC for Neuroendocrine Neoplasms
Jiale Hou, Tingting Long, Yi Yang, et al.
Molecular Imaging (2022) Vol. 2022
Open Access | Times Cited: 5
Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms
Giuseppe Fanciulli, Anna La Salvia, Sergio Di Molfetta, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 24, pp. 7557-7557
Open Access | Times Cited: 2
Serum tumor markers for detection of bone metastases in patients with lung neuroendocrine neoplasms”
Violetta Rosiek, Monika Wójcik-Giertuga, Beata Kos‐Kudła
Cancer Treatment and Research Communications (2022) Vol. 31, pp. 100533-100533
Open Access | Times Cited: 3
Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors
Maxime Lelièvre, Elizabeth Katherine Anna Triumbari, Hédia Brixi, et al.
Endocrine (2022) Vol. 78, Iss. 2, pp. 380-386
Closed Access | Times Cited: 3
Targeting Bone Metastasis in Cancers
Edith Bonnelye, Patricia Juárez
Cancers (2021) Vol. 13, Iss. 17, pp. 4490-4490
Open Access | Times Cited: 4
Correctly identifying the cells of origin is essential for tailoring treatment and understanding the emergence of cancer stem cells and late metastases
Helge L. Waldum, Geir Slupphaug
Frontiers in Oncology (2024) Vol. 14
Open Access
Diagnostic Anatomic Imaging for Neuroendocrine Neoplasms: Maximizing Strengths and Mitigating Weaknesses
Mina Hesami, Michael A. Blake, Mark Anderson, et al.
Journal of Computer Assisted Tomography (2024) Vol. 48, Iss. 4, pp. 521-532
Closed Access
Hypercalcemia and Bone Metastasis in a Case of Large Cell Neuroendocrine Carcinoma With Unknown Primary
Ekrem Yetiskul, Jordyn Salak, Fatema Arafa, et al.
Case Reports in Oncological Medicine (2024) Vol. 2024, pp. 1-6
Open Access
The Application of 68Ga-Somatostatin Analogue and 18F-FDG PET/CT for Bone Metastasis from Neuroendocrine Tumors
Liyan Bai, Junyan Xu, Xiaoping Xu, et al.
Neuroendocrinology (2024) Vol. 114, Iss. 8, pp. 775-785
Closed Access
Page 1 - Next Page

Scroll to top